These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27581849)

  • 21. Myasthenia gravis: presentation and outcome in 104 patients managed in a single institution.
    Al-Moallem MA; Alkali NH; Hakami MA; Zaidan RM
    Ann Saudi Med; 2008; 28(5):341-5. PubMed ID: 18779641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on juvenile myasthenia gravis.
    Liew WK; Kang PB
    Curr Opin Pediatr; 2013 Dec; 25(6):694-700. PubMed ID: 24141560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcome of 424 childhood-onset myasthenia gravis patients.
    Gui M; Luo X; Lin J; Li Y; Zhang M; Zhang X; Yang M; Wang W; Bu B
    J Neurol; 2015; 262(4):823-30. PubMed ID: 25588729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Juvenile myasthenia gravis in Norway: HLA-DRB1*04:04 is positively associated with prepubertal onset.
    Popperud TH; Viken MK; Kerty E; Lie BA
    PLoS One; 2017; 12(10):e0186383. PubMed ID: 29036181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delayed remission after thymectomy for myasthenia gravis of the purely ocular type.
    Nakamura H; Taniguchi Y; Suzuki Y; Tanaka Y; Ishiguro K; Fukuda M; Hara H; Mori T
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):371-5. PubMed ID: 8751505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment Outcomes and Predictive Factors in Pediatric Ocular Myasthenia Gravis.
    Kraithat P; Hansapinyo L; Patikulsila P
    J Med Assoc Thai; 2015 Sep; 98(9):883-8. PubMed ID: 26591399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of myasthenia gravis: a population-based study in Stockholm, Sweden.
    Kalb B; Matell G; Pirskanen R; Lambe M
    Neuroepidemiology; 2002; 21(5):221-5. PubMed ID: 12207149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tests for juvenile myasthenia gravis: comparative diagnostic yield and prediction of outcome.
    Afifi AK; Bell WE
    J Child Neurol; 1993 Oct; 8(4):403-11. PubMed ID: 8228040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myasthenia gravis in children: long-term follow-up.
    Rodriguez M; Gomez MR; Howard FM; Taylor WF
    Ann Neurol; 1983 May; 13(5):504-10. PubMed ID: 6870202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myasthenia gravis in Ceará, Brazil: clinical and epidemiological aspects.
    Aguiar Ade A; Carvalho AF; Costa CM; Fernandes JM; D'Almeida JA; Furtado LE; Cunha FM
    Arq Neuropsiquiatr; 2010 Dec; 68(6):843-8. PubMed ID: 21243239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long term effect of thymectomy for patients with myasthenia gravis].
    Yao Y; Chen Z; Pang L; Mao L
    Zhonghua Wai Ke Za Zhi; 1999 Jun; 37(6):353-4. PubMed ID: 11829859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response to treatment in pediatric ocular myasthenia gravis.
    Xu L; Castro D; Reisch JS; Iannaccone ST
    Muscle Nerve; 2020 Feb; 61(2):226-230. PubMed ID: 31650555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The prognosis of juvenile myasthenia gravis].
    Toifl K; Zeitlhofer J; Vass B
    Padiatr Padol; 1988; 23(3):195-207. PubMed ID: 3186266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lifetime course of myasthenia gravis.
    Grob D; Brunner N; Namba T; Pagala M
    Muscle Nerve; 2008 Feb; 37(2):141-9. PubMed ID: 18059039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Late-onset myasthenia gravis: a review when incidence in older adults keeps increasing.
    Alkhawajah NM; Oger J
    Muscle Nerve; 2013 Nov; 48(5):705-10. PubMed ID: 23893883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and impact of autoimmune thyroid disease on myasthenia gravis course.
    Kubiszewska J; Szyluk B; Szczudlik P; Bartoszewicz Z; Dutkiewicz M; Bielecki M; Bednarczuk T; Kostera-Pruszczyk A
    Brain Behav; 2016 Oct; 6(10):e00537. PubMed ID: 27781146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Juvenile myasthenia gravis.
    Chiang LM; Darras BT; Kang PB
    Muscle Nerve; 2009 Apr; 39(4):423-31. PubMed ID: 19229875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of children with acetylcholine receptor (AChR) antibody positive juvenile myasthenia gravis following thymectomy.
    Heng HS; Lim M; Absoud M; Austin C; Clarke D; Wraige E; Reid C; Robb SA; Jungbluth H
    Neuromuscul Disord; 2014 Jan; 24(1):25-30. PubMed ID: 24239058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myasthenia gravis: changes observed in a 30-years retrospective clinical study of a hospital-based population.
    Potagas C; Dellatolas G; Tavernarakis A; Molari H; Mourtzouhou P; Koutra H; Matikas N; Balakas N
    J Neurol; 2004 Jan; 251(1):116-7. PubMed ID: 14999503
    [No Abstract]   [Full Text] [Related]  

  • 40. Juvenile myasthenia gravis: recommendations for diagnostic approaches and treatment.
    Della Marina A; Trippe H; Lutz S; Schara U
    Neuropediatrics; 2014 Apr; 45(2):75-83. PubMed ID: 24470240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.